1-5 of 5
Authors: Dana Rizk
Journal Article
#4333 A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF BION-1301 IN ADULTS WITH IGA NEPHROPATHY
Nephrology Dialysis Transplantation, Volume 38, Issue Supplement_1, June 2023, gfad063c_4333, https://doi.org/10.1093/ndt/gfad063c_4333
Published: 14 June 2023
Journal Article
MO148A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, PARALLEL GROUP, PHASE III STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LNP023 IN PRIMARY IGA NEPHROPATHY PATIENTS
Nephrology Dialysis Transplantation, Volume 36, Issue Supplement_1, May 2021, gfab092.0026, https://doi.org/10.1093/ndt/gfab092.0026
Published: 29 May 2021
Journal Article
FP117SAFETY AND EFFICACY OF BARDOXOLONE METHYL IN PATIENTS WITH RARE CHRONIC KIDNEY DISEASES
Nephrology Dialysis Transplantation, Volume 34, Issue Supplement_1, June 2019, gfz106.FP117, https://doi.org/10.1093/ndt/gfz106.FP117
Published: 13 June 2019
Journal Article
FP806INITIAL RESULTS FROM A PHASE 2 TRIAL OF THE SAFETY AND EFFICACY OF BARDOXOLONE METHYL IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE AND IGA NEPHROPATHY
Nephrology Dialysis Transplantation, Volume 33, Issue suppl_1, May 2018, Page i635, https://doi.org/10.1093/ndt/gfy146.FP806
Published: 28 May 2018
Journal Article
FP110A PHASE 2 TRIAL OF THE SAFETY AND EFFICACY OF BARDOXOLONE METHYL IN PATIENTS WITH RARE CHRONIC KIDNEY DISEASES
Nephrology Dialysis Transplantation, Volume 33, Issue suppl_1, May 2018, Page i14, https://doi.org/10.1093/ndt/gfy104.FP110
Published: 18 May 2018
